ARTICLE | Company News
EMA to review Helsinn CINV product
January 30, 2014 2:18 AM UTC
EMA accepted for review an MAA from Helsinn Healthcare S.A. (Pazzallo-Lugano, Switzerland) for NEPA to prevent acute and delayed chemotherapy-induced nausea and vomiting (CINV). The product is also un...